PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 3, 2013, Pages 297-302

  Wanat, Matthew ^a   Fitousis, Kalliopi ^a   Hall, Jeff ^a   Rice, Lawrence ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

heparin; heparin antibody test; heparin induced thrombocytopenia; HIT; PF4 heparin; thrombocytopenia

Indexed keywords

HEPARIN PLATELET FACTOR 4 ANTIBODY;

ADULT; AGED; ARTICLE; CRITICALLY ILL PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTOPENIA;

HEPARIN; HEPARIN ANTIBODY TEST; HEPARIN-INDUCED THROMBOCYTOPENIA; HIT; PF4/HEPARIN; THROMBOCYTOPENIA;

ADULT; AGED; ANTIBODIES; ANTICOAGULANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PLATELET FACTOR 4; PROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 84878887418     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612438709     Document Type: Article

References (24)

1. Haines ST, Racine E, Zoella M Pharmacotherapy: A Pathophysiologic Approach. DiPirio JT, ed. New York, NY: McGraw-Hill Companies Inc ; 2002: 367-369.
2. Warkentin TE. Heparin-induced thrombocytopenia: diagnosis and management. Circulation. 2004 ; 110 ((18)). e454 - e458
3. Arepally GM, Ortel TL. Clinical practice: heparin-induced thrombocytopenia. N Engl J Med. 2006 ; 355 ((8)). 809-817
4. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med. 1995 ; 332 ((20)). 1330-1335
5. Shantsila E, Lip GY, Chong BH. Heparin-induced thrombocytopenia: a contemporary clinical approach to diagnosis and management. Chest. 2009 ; 8: 2330
6. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia. American college of chest physicians evidence-based clinical practice guidelines, 8th ed. Chest. 2008 ; 133 ((6 suppl)). 340S - 380S
7. Priziola JL, Smythe MA, Dager WE. Drug-induced thrombocytopenia in critically ill patients. Crit Care Med. 2010 ; 38 ((6 suppl)). S145 - S154
8. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, FLahault A. Thrombocytopenia in a surgical ICU. Chest. 1999 ; 115 ((5)). 1363-1370
9. Selleng K, Warkentin TE, Greinacher A. Heparin induced thrombocytopenia in intensive care patients. Crit Care Med. 2007 ; 35 ((4)). 1165-1176
10. Bakchoul T, Giptner A, Najaoui A, et al. Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2009 ; 7 ((8)). 1260-1265
11. Creekmore FM, Oderda GM, Pendleton RC, Brixner DI. Incidence and economic implication of heparin-induced thromboxytopenia in medical patients receiving prophylaxis for venous thromboembolism. Pharmacotherapy. 2006 ; 26 ((10)). 1438-1445
12. Dang CH, Durkalski VL, Nappi JM. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2006 ; 26 ((4)). 261-468
13. Yves G, Regina S, Pouplard C. Usefulness of pretest clinical score (4Ts) combined with immunoassay for the diagnosis of heparin-induced thrombocytopenia. Curr Opin Pulm Med. 2008 ; 14 ((5)). 397-402
14. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006 ; 4 ((4)). 759-765
15. Strutt JK, Mackey JE, Johnson SM, Sylvia LM. Assessment of the 4Ts pretest clinical scoring system as a predictor of heparin-induced thrombocytopenia. Pharmacotherapy. 2011 ; 31 ((2)). 138-145
16. Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T's score. J Thromb Haemost. 2010 ; 8 ((7)). 1483-1485
17. Crowther MA, Cook DJ, Albert M, et al. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care. 2010 ; 25 ((2)). 287-293
18. Zoumot Z, Davies JO, Patel PB. An analysis of the 4T's score in diagnosing heparin induced thrombocytopenia in critically ill patients. Am J Respir Crit Care Med. 2009 ; 179 ((1)). A3120
19. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008 ; 6 ((8)). 1304-1312
20. Test Menu for the University of Illinois at Chicago - Esoterix Coagulation Affiliation. Division of Clinical Pathology - University of Illinois Chicago. http://www.uic.edu/depts/mcpt/clinical/pdf/esoterix.pdf
21. Nasraway SA, Shorr AF, Kuter DJ, O'Grady NO, Le VH, Sammarata SK. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Clin Infect Dis. 2003 ; 11 ( ): 1609-1616
22. Lexi-Comp Online™, Lexi-Drugs Online™, Hudson, Ohio: Lexi-Comp, Inc.; 2011. http://webstore.lexi.com/s.nl/ctype. KB/it.I/id.342/KB.3234/.f
23. Wade EE, Rebuck JA, Healey MA, Rogers FB. H2 Antagonist-induced thrombocytopenia: is this a real phenomenon?. Intensive Care Med. 2002 ; 28 ((4)). 459-465
24. Ecker RD, Wijdicks EF, Wix K, McClelland R. Does famotidine induce thrombocytopenia in neurosurgical patients?. J Neurosurg Anesthesiol. 2004 ; 16 ((4)). 291-294